+1 310 883 6484 jrosenthal@cooley.com
James Rosenthal advises companies, entrepreneurs, venture capital and private equity investors, and financial institutions in complex and transformative transactions, with an emphasis on mergers and acquisitions.
Download full bio
Humio Agrees to Sell to CrowdStrike for $400 Million
Nuvation Bio to Combine With Panacea, a Special Purpose Acquisition Company
BookheadEd Agrees to Sell to Weld North Education
Canoo to List on Nasdaq Through Hennessy Capital Merger
Hyliion to Combine With Tortoise, a Special Purpose Acquisition Company
View all
Emerging Companies
Mergers & Acquisitions
Venture Capital
Private Equity
University of Pennsylvania Law SchoolJD, 2014
Wesleyan UniversityBA, History2008
New York
California
Humio Agrees to Sell to CrowdStrike for $400 Million February 25, 2021
Nuvation Bio to Combine With Panacea, a Special Purpose Acquisition Company October 28, 2020
SPAC Transactions – Considerations for Target-Company CFOs October 2, 2020
American Bar Association
+1 310 883 6484 office jrosenthal@cooley.com
1333 2nd StreetSuite 400Santa Monica, CA 90401